IMC Chicago’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
DGM
IMC Chicago's ABVX Position: Q3 2026 in Review
IMC Chicago increased its Abivax (ABVX) stake by 38% in Q3 2026, buying an estimated $4.05M and bringing the position to 120,966 shares worth $12M. The position accounts for ﹤0.01% of the portfolio, ranked #1504.
IMC Chicago first reported a position in ABVX in Q4 2025 and has held it in 4 quarters since. 317 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- IMC Chicago held 120,966 shares of Abivax worth $12M as of Q3 2026.
- IMC Chicago bought 33,574 Abivax shares in Q3 2026, an estimated $4.05M.
- Abivax made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #1504 holding.
- IMC Chicago first reported a position in Abivax in Q4 2025 and has held it in 4 quarters since.
- 317 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.